Brain Mapping Instruments Market Expected to Reach $3.7 Billion by 2031 | CAGR of 6.1%

Brain mapping instruments market was valued at $2.1 billion in 2021, and is estimated to reach $3.7 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031. Brain mapping is a technique that is used to study the functions and structure of various regions of the brain. Brain mapping is also used for the recording of brain wave activities. It helps surgeons to identify brain areas that are responsible for different functions in the body like vision, sensation, movement, and speech. Brain mapping also helps to detect various abnormalities like seizures, toxic injuries, tumors, Alzheimer’s diseases and other infections. Brain mapping helps to identify the external environment which changes brain structure and the reason for brain diseases and mental illness.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

Koninklijke Philips N.V., Compumedics Limited, Advanced Brain Monitoring, Inc., Medtronic plc, General Electric Company, Elekta AB, Siemens AG, Nihon Kohden Corporation, Brain Products GmbH, Brainscope Company Inc.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/15186

On the basis of product type, the market is classified into computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), near-infrared spectroscopy (NIRS), magnetic resonance imaging (FMRI) and others. The positron emission tomography (PET) segment is projected to exhibit the fastest market growth during the forecast period, owing to an increase in the adoption of electroencephalography (EEG) and rise in the number of diagnostic procedures for neurological conditions. For instance, according to the data by World Health Organizations, in February 2023, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.

On the basis of end user, the market is classified into hospitals, clinics, ambulatory centers and others. The ambulatory centers segment is anticipated to grow at the highest rate, owing to an upsurge in demand for brain mapping instruments among the hospitals. Moreover, the increase in the number of ambulatory surgery centers, and the rise in the number of product launches and advancements in brain mapping instruments also contribute toward the growth of the market. For instance, in July 2021, Omniscient Neurotechnology announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Quicktome, a digital brain mapping platform that allows neurosurgeons to visualize and understand a patient’s brain networks prior to performing life-changing brain surgery.

On the basis of region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA). In 2021, North America was the dominant Brain Mapping Instruments Market Share and is expected to remain dominant throughout the forecast period, owing to high expenditure in the research and development activities by the market players, increase in the number market players present in the region and surge in the product launches in the region. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to increase in the number of patients of brain diseases which helps to accelerate the demand for brain mapping instruments and the increase in number of strategies and trends adopted by the market players like product launch and acquisition.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/15186

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com